This curriculum vitae summarizes the qualifications and experience of Milan Mahboob. He has over 15 years of experience working in quality assurance and operations for Eskayef Pharmaceuticals Limited, and currently holds the position of Assistant General Manager of Quality Operations. He has a Master's degree in Pharmaceutical Technology and a Bachelor's degree in Pharmacy. His responsibilities include managing quality assurance operations, auditing, and ensuring compliance with cGMP guidelines.
This is the report of my first Summer training in BBA at Lupin, Ankleshwar plant. This whole report is prepared by me with the help of information provided by the company. Production, Dispatch, Store-warehouse, Purchase, Financial, HR departments are included in this project.
This project also include a Mini Project on "Job Satisfaction". I complete this project with the help of Random Survey method. I hop this report will help you in your study.
For any kind of query or correction in the project contact me through
email- rajat.gandhi27@gmail.com
facebook- www.facebook.com/rajat.gandhi28
Pharma third party manufacturing companies in Baddi | PharmaaddaAditiMehra14
Looking for the best Pharma third Party Manufacturing Companies in Baddi then visit this blog and get information about contract manufacturing in Baddi. http://www.pharmaadda.in/pharma-third-party-manufacturing-companies-in-baddi
This is the report of my first Summer training in BBA at Lupin, Ankleshwar plant. This whole report is prepared by me with the help of information provided by the company. Production, Dispatch, Store-warehouse, Purchase, Financial, HR departments are included in this project.
This project also include a Mini Project on "Job Satisfaction". I complete this project with the help of Random Survey method. I hop this report will help you in your study.
For any kind of query or correction in the project contact me through
email- rajat.gandhi27@gmail.com
facebook- www.facebook.com/rajat.gandhi28
Pharma third party manufacturing companies in Baddi | PharmaaddaAditiMehra14
Looking for the best Pharma third Party Manufacturing Companies in Baddi then visit this blog and get information about contract manufacturing in Baddi. http://www.pharmaadda.in/pharma-third-party-manufacturing-companies-in-baddi
Concepts of GLP and ISO 9000. The Good Laboratory Practices Guideline (GLP) is an FDA regulation. Good Laboratory Practices (GLP) embodies a set of principles that provides a framework within which laboratory studies are planned, performed, monitored, recorded and reported. National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA). NGCMA was established by the Department of Science & Technology (DST), Government of India, with the approval of the Union Cabinet on April 24, 2002.
ISO 9000 is a series of standards, developed and published by the International Organization for Standardization (ISO), which is an independent, non-governmental organization made up of members from over 160 countries.
The ISO 9000 family of standards is related to Quality Management Systems and designed to help organizations ensure that they meet the needs of customers and other stakeholders while meeting statutory and regulatory requirements. ISO 9000 deals with the fundamentals of quality management systems, including the 7 Quality Management Principles on which the family of standards is based.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Resume of Milan Mahboob
1. Curriculum Vitae of Milan Mahboob
MILAN MAHBOOB
Name : Milan Mahboob
Father’s Name : Abdul Awal
Place of Birth : Chittagong
Date of Birth : January 09, 1978
Marital Status : Married
Religion : Islam
Nationality : Bangladeshi
Blood Group : B (+)ve
Professional identity : Registered Pharmacist (Registration No. A-2213)
Hobbies : Book, Stamp, Coin collection and Traveling
Strength : Honest, Industrious, Self motivated, Target Oriented, Acclimatization,
Dynamic, Keen Observer and lastly Non smoker.
Sightsee experience : French, Denmark, India, China, Malaysia, Thailand, Korea, Indonesia, Singapore
and UAE
Educational Background:
M S. Pharmaceutical Technology from University of Asia Pacific, Dhanmondi, Dhaka 2006 with CGPA 3.16.
Bachelor of Pharmacy from University of Asia Pacific, Dhanmondi, Dhaka 2002 with CGPA 3.54.
Higher Secondary School Certificate from B. A. F. Shaheen College, Kurmitola, Dhaka 1995 with first division.
Secondary School Certificate from B. A. F. Shaheen College, Kurmitola, Dhaka 1993 with first division.
Present & Permanent Address:
“Sopno Bilas”
39 (04), Borodewra, Fakir Market,
Tongi, Gazipur
Mobile: 01714072669, 01974072669
Email: mahboobmilan@yahoo.com,
Milan@skf.transcombd.com
2. Curriculum Vitae of Milan Mahboob
Professional Background:
I am working as an Assistant General Manager Quality Operations in Eskayef Pharmaceuticals Limited, a
MHRA, TGA and VMD certified pharmaceutical company. On March 2002 I joined as Quality Assurance Officer.
Professional accomplishment
March 2002 - June 2003 as Quality Assurance Officer
July 2003 - June 2005 as Sr. Quality Assurance Officer
July 2005 - June 2007 as Assistant Manager Quality Assurance
July 2007 - December 2008 as Deputy Quality Compliance Manager
January 2009 – 2011 as Quality Compliance Manager
January 2012 – December 2014 as Senior Quality Compliance Manager
January 2015 – December 2016 as Senior Quality Assurance Manager
January 2017 to December 2017 as Head of Quality Units (Graded as AGM QA)
January 2018 to till now as AGM Quality Operations
Key responsibility as AGM Quality Operations for cephalosporin generic product and active pharmaceutical
ingredient in Eskayef Pharmaceuticals Limited Other key professional activity:
Act as a Lead Auditor (GXP) of Eskayef Pharmaceuticals Limited.
Act as a Safety Lead Auditor
Act as a specialist on sterile and non-sterile product/facility trouble shooter.
Act as a specialist on Quality Management System e.g. Deviation & investigation, OOS, Change Request, CAPA,
Recall and Complaint.
Act as a coordinator on Pharmacovigilance Activities.
Act as specialist in pharmaceutical engineering concern.
Key Professional Achievement:
- Experience on “Pharmaceutical manufacturing and Lab instrumentation” of Tablet, Capsule, Liquid,
Cream and ointment, Ophthalmic preparation, Solid sterile preparation, ORS and effervescent product,
Powder for suspension, Pellets and Sustain Release preparation, insulin manufacturing and it’s
troubleshooting. In addition I have experience in working both plant of Eskayef Pharmaceutical Ltd,
Mirpur, Tongi, Volta and Salna.
- Conduct more than 60 man-days audit on GMP and safety locally and internationally.
- Experience in managing cleaning, process (manufacturing & packaging), Process simulation,
validation/qualification of equipment and utility.
- Experience on quality control and microbiological activity.
- I have experience in facing audit of overseas regulatory agency such as, MHRA, TGA, GSK Global
(pharma and consumer), Servier, Novartis Global, Novo Nordisk and Medreich (UK), Iran, Nepal, Uganda,
Yemen and Kenyan drug Regulatory Agency.
- Also have
3. Curriculum Vitae of Milan Mahboob
Auditing experience in local and international industries such as Bangladesh Antibiotic Industries Limited of Beximco
Pharmaceutical Limited, Padma Cap and Padma Blowing industries, RAK Ghani, UAE, Nectar Lifesciences Ltd,
JMI Syringe, India, Ranbaxy Laboratories Limited, India, Parabolic Drugs Ltd., India, ESS DEE Aluminium
Limited, India and Nip Chemicals And Pharmaceutical Ltd, Bangladesh, Henan Dongtai Company Ltd. China,
Shezhen Salubris Pharmaceutical Co. Ltd, Shanxi JC Biological Technology Co. Ltd. China,Viwit Pharmaceutical
Co. Ltd. China, Weifang Shengtai Medicine Co. ltd, China (Shangdong), Shantou Jiahe Biologic Technology Co.,
Ltd, Senxing Pharmaceutical Consumable (Beijing) Ltd. China (Beijing) etc. as a part of Vendor audit.
Experience on visiting local and overseas companies such as
- Beximco Pharmaceutical Ltd. and Renata Ltd.
- Bengal Chemicals & Pharmaceuticals Ltd. Kolkata, Shanghai Pudong Freeze Drying Equipment Co., Ltd.,
Shandong Weifang Eagle Medical Appliance Co., Ltd, Hunan China Sun Pharmaceutical Machinery Co. Ltd.,
Shanghai Tofflon Science & Technology Co. Ltd. China and Novo Nordisk, Denmark.
Key Responsibilities:
1. To manage the Quality Assurance Operations (i.e. Quality Control, Quality Compliance,
In process Control and Microbiology) in cephalosporin block to ensure total quality as per
control procedures and cGMP and/or regulatory guides.
2. To handle Deviation, OOS, Change Request and CAPA, Product Complaint and its
supportive activities.
3. To audit different sections of plant in a regular interval in order to meet GMP/GLP
requirements and new or existing vendor(s).
4. To approve the analytical methods, process, cleaning equipment validation and
technology transfer of contract customer.
5. Act as designee of Director QA for Quality and administrative issue, whenever required.
6. To coordinate the Pharmacovigilance issue and give response to DGDA (Local drug
regulatory) and Contact Customer.
7. To Coordinate Health Safety and Environment Issue as per Local regulation and ISO
18001 & OSHAS 14001.
8. Act as a lead Auditor for GxP and HSE issues for the site.
Other Duties & Responsibilities:
To monitor Health and Safety of the personnel and supervise health card maintenance.
To coordinate among engineering and production dept. and organize Fire and safety
drill twice a year.
To audit agronomies, fire, safety, occupational health & safety assessment as
Certificated Auditor of OHSAS 18000: 2007 (IRCA, UK)
To coordinate among all the concerned dept. to ensure Environment Management
System.
4. Curriculum Vitae of Milan Mahboob
Training Attendee:
- Attend training on “PMP exam preparation course” organized by Eskayef Bangladesh Limited by Shabnam Suri
(Singapore) PMP, Prince 2, MBA (MIS) Australia on March 2017 (32 Hours).
- Attend training on: "How to start and maintain Pharmacovigilance activity based on Bangladesh
Drug Administration requirement” organized by consultancy firm PVCON
by Mr. Moin Don in Bankok, 2-3 March 2015 (16 Hours).
- Attend training on “Computerized System Validation and GAMP 5” organized by Eskayef Bangladesh Limited
by Dr. Rob Stephenson, It system Validation consultation, UK and ECA panel member in December 2014 (16
Hours).
- Attend training on “Essential of pharmaceutical regulators’ Affair’s” organized by Eskayef Bangladesh
Limited , by Bharti Khanna, Chief Operating Officer, YES regulatory Healthcare Services: Yes group New Delhi
Area, India in December 2014 (16 hours).
- Attend training “Quality by Design, QBD” organized by Eskayef Bangladesh Limited by Nagesh Nanda Novel
Consultants, Gujrat, India in December 2014 (8 hours).
- Attend training “Organization of CTD- eCTD and Technical/CMC writing skills” organized by Eskayef
Bangladesh Limited by Ms Rajqshi Ojha, Founder and Managing Director of Global Pharma Regulatory Affairs
Consultants, India in March 2014 (7 hours).
- Attend in training “Vendor Audit as a Lead Auditor” organized by Incepta Pharmaceutical Limited, by Rob
Walker Director, Rob Walker GMP and MHRA Consultancy Ltd. UK in July 2011 (7 hours).
- Attend in “Practical Insulin School” to gained insight into formulation and practical production of products,
supplemented with relevant theory, arranged by Novo Nordisk in October 2010 (14 hours).
- Attend in “Contract manufacturing for pharmaceuticals and biotech companies” organized by Global
strategy exchange at Dhaka, Sheraton Hotel, Dhaka in March 2010 (14 hours).
- “Regulatory compliance", "Quality system Design and Implementation", "Process & quality
Documentation", “Validation: Process, Equipment and Cleaning” and “Injectable Preparation” by Asia Pacific
Consultants Pty. Ltd. at Eskayef Bangladesh Ltd in June and September 2006 (35 and 21 hours).
- "ISO 14000 & OHSAS 18000: HSE Management" by Md. Golam Kibria Lead Auditor ISO 9000 and Auditor
ISO 14000/SA 8000 of Bureau Veritas (Bangladesh) Private Ltd in September 2006 (7 hours).
- Lead Auditor course on OHSAS 18000: 2007 (Occupational Health & Safety Assessment Series) certified
by International Register for Certificated Auditor (IRCA, UK)" organized by Bureau Veritas (Bangladesh)
Private Ltd. in August 2008 (40 hours).
- “Learning and Implementation Techniques for GMP Trainers” of Pharmaceutical GMP issues by Asia
Pacific Consultants Pty Ltd. Australia in March 2007 (16 hours).
- “Research Methodology and Pharmaceutical with the application of SPSS” by Bangladesh Institute of
Management (BIM) in May 2007 (40 Hours).
- “Social Compliance Knowledge and Law” by Dani Resource Center in March 2007 (7 hours).
- “Fire and Safety training” by Fire Service and Civil Defense organized by Eskayef Bangladesh Ltd. at
factory Premises in November 2007 (21 Hours).
- “Bangladesh Labor Act, 2006” Organized by Syed Azadul Huq, Advocate and Consultant of Labor Law
and Labor Management in March 2008 (8hours).
- “Basic Health Economics issues in Bangladesh health sector” organized by Dept. of Health Economics,
University of Dhaka in March 2008 (45 hours).
- “Waste Water Management” organized by Dept. of Environment at China Bangladesh Conference Center
in 2007 (10 Hours).
5. Curriculum Vitae of Milan Mahboob
- “Total Quality Management in Business and Industries” organized by Directorate of Continuing Education &
Dept. of Industrial and Production Engineering of Bangladesh University of Engineering & Technology in June 2008
(10 hours).
- “ Management Skills” by Abdul Quaderi, Trainer and Consultant of Carrier Design International, Brisbane
Australia at Eskayef Bangladesh Ltd in June 2007 (4 hours).
- “Energy and Environment” organized by Centre for Energy Studies (CES), BUET and GTZ in November 2009
(14 hours).
Computer Skill:
Well knowledge in office management, statistical and editing software.
Research Experience:
I have research experience on 9-month sustained release dosage form implants and 8-month pellet
technology.
Publications:
- “DEMAND SUPPLY AND THE MARKET STATUS OF INSULIN PRODUCTS IN BANGLADESH” in “The
Bangladesh Journal of Scientific Research” and
- “IN VITRO RELEASE PROFILE OF DICLOFENAC SODIUM FROM POLYMERIC MULTI-UNIT SYSTEM” in
“Journal of Biological Science, Dhaka University” are two publication has been published.
Seminar Participation:
Rewarded first prize for my presentation in the seminar on “Total Employee Participation for Achieving
Excellence” organized by Bangladesh Society for Total Quality Management (BSTQM); The Institution of
Engineers, Bangladesh; and Bangladesh AOTS Alumni Society.
Professional Achievement:
- Project Management of HVAC, Production facility and Warehouse, Water treatment (PW, WFI, PS) ,
Environment Management System e.g. Effluent Treatment Plant
- Experience on MHRA, VMD and TGA Certification
- Opportunity to work with international consultant
David R Buckley FQSA
GMP Consultant, CEO
David Buckley & Associate Pty Ltd, Australia
www.navigategmp.com
Roger A Large CChem MRSC MCMI
Director
RL Process Solutions Limited, UK
James MacLaughlin
Principal Consultant & President
JMAC GMP Consulting, LLC
Greater Atlanta Area
Rob Walker BSc MSc CChem FRSC
Director
Rob Walker GMP and MHRA Consultancy
Ltd. UK
Wayne Mc Kenzie
Director
Waytotrain Pty Ltd.
TGA Consultant
Corporate Training & Consultancy, Australia
6. Curriculum Vitae of Milan Mahboob
Reference:
Dr. Reza-ul Jalil, Pharmacist
Professor and Pharmacist
Department of Pharmacy
Dhaka University
Phone: 9120325 (Res.) 9661900-73 Ext.8175, 8179, 8176 (off.)
Mobile: 01713014208
Ms. Asma Reza
DGM Quality Operations and Pharmacist
Eskayef Pharmaceutical Limited
Mobile: 01713065409
Phone: 8011445, 8011395 Ext 140 (off)
Dr. Mahboob Hossain,
Professor and Microbiologist
Brac University
Mobile: 0152324230
Milan Mahboob